Sam A (Korea) Today
| 009300 Stock | KRW 17,310 240.00 1.37% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Sam A is trading at 17310.00 as of the 29th of November 2024, a 1.37 percent decrease since the beginning of the trading day. The stock's open price was 17550.0. Sam A has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Sam A Pharm Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of June 2023 and ending today, the 29th of November 2024. Click here to learn more.
Co., Ltd operates as a pharmaceutical company in South Korea. Co., Ltd was founded in 1945 and is based in Seoul, South Korea. Sam A is traded on Korean Securities Dealers Automated Quotations in South Korea. The company has 6.1 M outstanding shares. More on Sam A Pharm Co
Moving together with Sam Stock
| 0.81 | 102940 | Kolon Life Science | PairCorr |
| 0.88 | 074430 | Aminologics CoLtd | PairCorr |
| 0.84 | 330350 | Withuspharmaceutical | PairCorr |
Moving against Sam Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sam Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sam A's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sam A or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceuticals, Healthcare (View all Sectors) |
Sam A Pharm Co (009300) is traded on KOSDAQ in Korea and employs 287 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 108.64 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sam A's market, we take the total number of its shares issued and multiply it by Sam A's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sam A Pharm operates under Healthcare sector and is part of Pharmaceuticals industry. The entity has 6.1 M outstanding shares.
Sam A Pharm Co has accumulated about 7.98 B in cash with 12.94 B of positive cash flow from operations.
Check Sam A Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Sam A is W108.64 Billion. Sam A Pharm has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 65.58 % of Sam A outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with substantial debt, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
Check Sam Ownership Details
Sam A Pharm Risk Profiles
Although Sam A's alpha and beta are two of the key measurements used to evaluate Sam A's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.66 | |||
| Standard Deviation | 1.99 | |||
| Variance | 3.98 | |||
| Risk Adjusted Performance | (0.18) |
Sam Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sam A without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Sam A Corporate Management
Elected by the shareholders, the Sam A's board of directors comprises two types of representatives: Sam A inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sam. The board's role is to monitor Sam A's management team and ensure that shareholders' interests are well served. Sam A's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sam A's outside directors are responsible for providing unbiased perspectives on the board's policies.
| KukHwan Choi | Managing Director | Profile | |
| Heo Jun | Chief Officer | Profile | |
| HyeonWu Lee | Managing Director | Profile | |
| ShinJun Kang | Managing Director | Profile | |
| HyeongCheol Nam | Managing Director | Profile |
Other Information on Investing in Sam Stock
Sam A financial ratios help investors to determine whether Sam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sam with respect to the benefits of owning Sam A security.